Afuco™ Anti-BSG ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-156) (CAT#: AFC-TAB-156)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD147. It is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. It proved slightly less effective than standard antithymocyte globulin therapy.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Gavilimomab
  • Related Disease
  • Allograft rejection

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • BSG; basigin (Ok blood group); basigin (OK blood group), OK; basigin; CD147; EMMPRIN; CD147 antigen; OK blood group antigen; collagenase stimulatory factor; leukocyte activation antigen M6;

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Gavilimomab"

DrugMonitor™ Anti-Gavilimomab Antibody (VS-1224-YC512)
Gavilimomab is a murine IgM monoclonal antibody (MoAb) developed as a potential treatment for graft-versus-host disease (GvHD). The DrugMonitor™ Anti-Gavilimomab Antibody (VS-1224-YC512) is an anti-drug antibody (ADA) against Gavilimomab. This drug-based antibody is raised in mice immunized with the Gavilimomab. The anti-Gavilimomab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Gavilimomab in samples.

See other products for "BSG"

Select a product category from the dropdown menu below to view related products.
Please select product type
Intrabody Products IgM Antibody Products ScFv Antibody Products Human Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products Neuroscience Antibody Products Fab Antibody Products IgG Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads ScFv-Fc Chimera Products
CAT Product Name Application Type
IAB-B050(A) Recombinant Anti-human BSG Intrabody [(D-Arg)9] WB, ICC, Neut, FuncS scFv-(D-Arg)9
IAB-B050(G) Recombinant Anti-human BSG Intrabody [+36 GFP] IF, FC, FuncS scFv-(+36GFP)
IAB-B050(T) Recombinant Anti-human BSG Intrabody [Tat] WB, ICC, FuncS scFv-Tat

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-156. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare